Evaluation of a Meds-to-Beds Program to Reduce Readmissions After Percutaneous Coronary Intervention
Authors' conclusion
A meds-to-beds program was not associated with readmission reduction among adults who received PCI. Other measures, such as medication adherence and patient satisfaction, could be employed to assess the effectiveness of future medication delivery programs.
Study context
- Population
- Medically underserved diverse cohort of adults who received emergent or elective percutaneous coronary intervention (PCI) at an academic medical center in Bronx County, NYpatients included
- Participants
- 662 participants
- Exposure
- Meds-to-beds program vs standard of care control group
- Outcome
- 30-day all-cause hospital readmissions
- Follow-up
- 30 days
Main finding
As reported in the abstract
Odds ratio
1.07
95% CI 0.58–1.97
By group
Interventionvs control
OR 1.07 (95% CI 0.58–1.97)
Observational data: associations, not effects.
Secondary outcomes
| Outcome | Intervention | Control | OR (95% CI) | |
|---|---|---|---|---|
| 30-day cardiac-related readmissions · after confounder adjustment; not significant | 2.9% | 6.3% | 0.50 (0.21–1.18) | |
| 0.20.5125Odds ratio (log scale) |
- 30-day cardiac-related readmissions: unadjusted rate significantly lower in the intervention group; association did not remain significant after confounder adjustment
Provider satisfaction
- Providers perceived that the intervention improved safety and quality during transitions of care
Original publication
Evaluation of a Meds-to-Beds Program to Reduce Readmissions After Percutaneous Coronary Intervention. JACC Adv. Published March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →